BioElectronics Investor Updates
Thursday, July 3, 2014
We are excited to announce that ActiPatch® is participating at the Back Pain Show in the UK this weekend!
Executive Vice President Deepak Kotak, MA (Oxford), MBBS, FRCA, MRCP, LLDip, LLM and BioElectronics’ President Andrew J. Whelan, will be interacting with the highly motivated audience seeking solutions to their back pain. The Back Pain Show is the UK’s only event dedicated to back pain. An estimated 6,000 visitors are anticipated to attend.
When: July 4-6, 2014
Where: Grand Hall, Olympia, London UK
Booth #: B47
UK Boots PR & Marketing Update
Since it was launched in 1999, 50Connect has grown rapidly as its broad mix of editorial, information and entertainment struck a chord with the over 50’s and those approaching that milestone.
ActiPatch was featured in an advertorial on their website:
An ActiPatch full page advertorial was featured in Inspire Magazine:
The print version was released the week of May 19. We are offering 7-Day ActiPatch samples to the members of the charity. A web banner and the ActiPatch video is included on their website.
“Try It and Tell Us” Facebook Social Media Program Builds Momentum and User Testimonials
UK Consumers Report ActiPatch® Therapy Reduces Pain, Including Fibromyalgia, Without Drugs
We have received positive early feedback from our “Try It and Tell Us” social media program in the United Kingdom that has attracted thousands of followers. The Facebook-based program offers U.K. and Irish consumers free trial devices, delivering a week of therapy, and then surveys them about their experience including self-reported pain personal experience.
The “Try It & Tell Us” sample program for United Kingdom and Ireland residents is working well with thousands of 7-day ActiPatch® Therapy samples already shipped. For first-hand testimonials from the consumers visit www.actipatch.com/testimonials or www.facebook.com/ActiPatch to see what people in the UK and Ireland are saying about the product.
“We’ve just begun tabulating the feedback, but it is very positive. Across the board ActiPatch Therapy reduced pain without drugs,” said Ian Rawe, Ph.D., Director of Clinical Research at BioElectronics Corporation. “While this is only an informal survey, it’s real world experience and we are beginning to see the benefits of ActiPatch Therapy with consumers suffering from long term chronic pain.
“The data exposed another important indication, fibromyalgia, a significant medical issue that causes suffers substantial pain that we have not previously studied in a formal clinical trial. Of the consumers who identified themselves as fibromyalgia sufferers, 70% said they had significant improvement in their pain levels — with the average improvement rated as 50% less pain,” Rawe said. In their testimonials many fibromyalgia sufferers cited specific improvements in localized pain in neck, shoulder and back.
BioElectronics will be an exhibitor at the 2014 FIME International Medical Trade Fair held this August in Miami, FL. FIME is the largest International Medical Trade Fair and Congress in the United States. The annual event is a purchasing show, drawing conventional distributor networks, group purchasing organizations, integrated delivery networks, hospitals, imaging centers, private practice facilities, and HME / DME providers. The dynamic attendee base is key to penetrating and navigating around complicated medical distribution channels and networks.
BioElectronics Booth #: 1785
Please visit http://www.bielcorp.com/fime-tradeshow-2014/ for more information.
BioElectronics Social Media
Connect with us through social media to receive company updates along with other valuable information:
Next Company Update: Thursday, August 7, 2014
To receive investor updates via e-mail, please contact us at IR@bielcorp.com with your name and e-mail address. Updates are posted every other Thursday. Thank you for your support!